DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

3503 reported adverse events

Drug classes: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]

These side effects are most commonly reported by patients taking DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE:

# Side effect Count
0 NAUSEA 233
1 BLOOD GLUCOSE INCREASED 232
2 DIARRHOEA 179
3 VOMITING 179
4 WEIGHT DECREASED 178
5 DIABETIC KETOACIDOSIS 177
6 OFF LABEL USE 176
7 FATIGUE 146
8 DRUG INEFFECTIVE 133
9 DEATH 129
See all common reactions for DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERINEAL CELLULITIS 5 0.0847
1 ACQUIRED PHIMOSIS 4 0.0336
2 EMPHYSEMATOUS PYELONEPHRITIS 6 0.0328
3 BALANITIS CANDIDA 4 0.0312
4 PERINEAL ABSCESS 12 0.0266
5 GENITAL ABSCESS 9 0.0223
6 DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA 4 0.0220
7 PHIMOSIS 13 0.0176
8 BALANOPOSTHITIS 14 0.0170
9 SCROTAL ABSCESS 6 0.0159
See all enriched reactions for DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE